Canagliflozin Delays Increase in Certain CV Biomarkers in T2DM
Canagliflozin may reduce CV, heart failure risk over two years versus placebo in older patients with T2DM
Revenue Exceeds Expenditures for Many ABMS Member Boards
Change in net balance of American Board of Medical Specialties member boards grew from 2003 to 2013
Less Than Half of Stroke Discharges Prescribed a Statin
Prescribing differences by age, sex seen in 'Stroke Belt' in the southern U.S. versus rest of nation
July 2017 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for July 2017. This roundup includes the latest...
New Research Supports Safety of Aspirin in Heart Failure
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths
Climate Change Expected to Up Premature Deaths From Pollution
Premature mortality attributable to climate change estimated to be greatest in India, East Asia
Sodium Intake >3.7 g/Day Linked to Adverse Cardiac Strain
Systolic BP explained some of the indirect effect between ESI and longitudinal strain, e' velocity
FDA Proposes Lowering Nicotine Levels in Cigarettes
Goal is to combat smoking by making it less addictive
Total, Saturated Fat Linked to Increased Risk of Lung Cancer
Pooled analysis shows substitution with polyunsaturated fat reduces risk of carcinoma
Interval Training Cuts CVD Risk in Testicular Cancer Survivors
High-intensity aerobic interval training improves cardiorespiratory fitness compared with usual care
